2009, Number S1
<< Back Next >>
Rev Mex Anest 2009; 32 (S1)
Current concepts in cardiogenic shock
González-Chon O, Sánchez-Zavala J, Arias-Sánchez E, García-López SMC
Language: Spanish
References: 8
Page: 65-67
PDF size: 63.19 Kb.
Text Extraction
No abstract
REFERENCES
Reynolds H. Hochmann J. Cardiogenic Shock current concepts and improving outcomes. Circulation 2008;117:686.
Topalian S. Cardiogenic Shock. Critical Care Med 2008;36:Er FA.
Golberg RJ, Spencer FA, Gore JM. Thirty year trends (1975-2005) in the magnitude of management of and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction. Circulation 2009;119:1211-1219.
Thiele H, Smalling RW, Scheler GC. Percutaneous left ventricular devices in acute myocardial infarction complicate by cardiogenic shock. European Heart J 2007;28:2057-2063.
Jeger RV, Lowe A, Buller Ch E, Pfisterer ME. Hemodynamics parameters are pronostically important in cardiogenic shock bur similar following early revascularization or initial medical stabilization. A Report from the SHOCK Trial Chest 2007;132:1794-1803.
Jeger RV, Radovanic D, Hunziker PR, Pfisterer. Ten year trends in the incidence and treatment of cardiogenic shock. Ann Inter Med 2008;149:618-629.
Fuhrmann JT, Schmeisser A, Schulze MR, Wunderlich C. Levosimendan in superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Critical Care Med 2008;36:2257-2266.
Dzavik V, Cotter G, Reynolds HR, Alexander JH. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose ranging study. European Heart Journal 2007;28:1109-1116.
Full text